Drugs / NAVX-010
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03655522 Comparator | May → Sep 2015 | — | Algenis SpA | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NAVX-010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03655522 ↗ |
| Route | Intramuscular | “Doses were administered as IM injections into the deltoid muscle in the fasted state.” NCT03655522 ↗ |